- Home
- OABI vs ARAI Comparison
OABI vs ARAI Comparison
Compare OABI & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ARAI
- Stock Information
- Founded
- OABI 2012
- ARAI 2020
- Country
- OABI United States
- ARAI United States
- Employees
- OABI N/A
- ARAI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ARAI Diversified Commercial Services
- Sector
- OABI Health Care
- ARAI Finance
- Exchange
- OABI Nasdaq
- ARAI Nasdaq
- Market Cap
- OABI 227.4M
- ARAI 213.7M
- IPO Year
- OABI N/A
- ARAI N/A
- Fundamental
- Price
- OABI $1.66
- ARAI $4.61
- Analyst Decision
- OABI Strong Buy
- ARAI
- Analyst Count
- OABI 3
- ARAI 0
- Target Price
- OABI $6.67
- ARAI N/A
- AVG Volume (30 Days)
- OABI 595.9K
- ARAI 580.0K
- Earning Date
- OABI 11-11-2025
- ARAI 08-14-2025
- Dividend Yield
- OABI N/A
- ARAI N/A
- EPS Growth
- OABI N/A
- ARAI N/A
- EPS
- OABI N/A
- ARAI N/A
- Revenue
- OABI $23,027,000.00
- ARAI $90,725.00
- Revenue This Year
- OABI N/A
- ARAI N/A
- Revenue Next Year
- OABI $48.74
- ARAI N/A
- P/E Ratio
- OABI N/A
- ARAI N/A
- Revenue Growth
- OABI 6.05
- ARAI N/A
- 52 Week Low
- OABI $1.22
- ARAI $3.03
- 52 Week High
- OABI $4.87
- ARAI $40.00
- Technical
- Relative Strength Index (RSI)
- OABI 49.38
- ARAI N/A
- Support Level
- OABI $1.58
- ARAI N/A
- Resistance Level
- OABI $1.72
- ARAI N/A
- Average True Range (ATR)
- OABI 0.08
- ARAI 0.00
- MACD
- OABI 0.02
- ARAI 0.00
- Stochastic Oscillator
- OABI 65.15
- ARAI 0.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ARAI Arrive AI Inc. Common Stock
Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.